PubMed:32418532 / 5302-5469 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T180","span":{"begin":12,"end":16},"obj":"G_3"},{"id":"T181","span":{"begin":12,"end":16},"obj":"PG_10"},{"id":"T182","span":{"begin":12,"end":16},"obj":"PR:000003622"},{"id":"T183","span":{"begin":132,"end":144},"obj":"CHEBI:17089"},{"id":"T184","span":{"begin":132,"end":144},"obj":"BV_11"},{"id":"T185","span":{"begin":132,"end":144},"obj":"CHEBI:17089"},{"id":"T186","span":{"begin":148,"end":158},"obj":"SP_7"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Recombinant ACE2 (under clinical trials) is also considered as a decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2 [9, 10]."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T31","span":{"begin":132,"end":144},"obj":"Body_part"}],"attributes":[{"id":"A31","pred":"fma_id","subj":"T31","obj":"http://purl.org/sig/ont/fma/fma62925"}],"text":"Recombinant ACE2 (under clinical trials) is also considered as a decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2 [9, 10]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T41","span":{"begin":148,"end":156},"obj":"Disease"}],"attributes":[{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Recombinant ACE2 (under clinical trials) is also considered as a decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2 [9, 10]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T74","span":{"begin":63,"end":64},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Recombinant ACE2 (under clinical trials) is also considered as a decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2 [9, 10]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T106","span":{"begin":132,"end":144},"obj":"Chemical"}],"attributes":[{"id":"A106","pred":"chebi_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"}],"text":"Recombinant ACE2 (under clinical trials) is also considered as a decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2 [9, 10]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"205","span":{"begin":12,"end":16},"obj":"Gene"},{"id":"206","span":{"begin":148,"end":158},"obj":"Species"}],"attributes":[{"id":"A205","pred":"tao:has_database_id","subj":"205","obj":"Gene:59272"},{"id":"A206","pred":"tao:has_database_id","subj":"206","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Recombinant ACE2 (under clinical trials) is also considered as a decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2 [9, 10]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T29","span":{"begin":0,"end":167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Recombinant ACE2 (under clinical trials) is also considered as a decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2 [9, 10]."}

{"project":"Covid19_manual_annotation_v2","denotations":[{"id":"T108","span":{"begin":12,"end":16},"obj":"Gene"},{"id":"T290","span":{"begin":0,"end":11},"obj":"Type"},{"id":"T291","span":{"begin":107,"end":114},"obj":"Phenomena"},{"id":"T292","span":{"begin":95,"end":106},"obj":"NegativeRegulation"},{"id":"T9","span":{"begin":148,"end":158},"obj":"Species"},{"id":"T99","span":{"begin":122,"end":144},"obj":"Gene"}],"relations":[{"id":"R206","pred":"of_a","subj":"T290","obj":"T108"},{"id":"R210","pred":"of_a","subj":"T9","obj":"T99"},{"id":"R261","pred":"is_a","subj":"T290","obj":"T292"},{"id":"R262","pred":"is_a","subj":"T292","obj":"T291"},{"id":"R263","pred":"to","subj":"T291","obj":"T108"},{"id":"R264","pred":"is_a","subj":"T99","obj":"T291"}],"attributes":[{"id":"A60","pred":"tao:has_database_id","subj":"T108","obj":"Gene:59272"},{"id":"A307","pred":"tao:has_database_id","subj":"T291","obj":"MESH:D011485"},{"id":"A52","pred":"tao:has_database_id","subj":"T99","obj":"Gene:43740568"},{"id":"A9","pred":"tao:has_database_id","subj":"T9","obj":"Tax:2697049"},{"id":"A298","pred":"tao:has_database_id","subj":"T290","obj":"MESH:D011994"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"BioProject","uri":"https://www.ncbi.nlm.nih.gov/bioproject/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"},{"prefix":"HP","uri":"https://hpo.jax.org/app/browse/term/HP:"},{"prefix":"BioSample","uri":"https://www.ncbi.nlm.nih.gov/biosample/"}],"text":"Recombinant ACE2 (under clinical trials) is also considered as a decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2 [9, 10]."}

{"project":"Zoonoses","denotations":[{"id":"T108","span":{"begin":12,"end":16},"obj":"Gene"},{"id":"T290","span":{"begin":0,"end":11},"obj":"Type"},{"id":"T291","span":{"begin":107,"end":114},"obj":"Phenomena"},{"id":"T292","span":{"begin":95,"end":106},"obj":"NegativeRegulation"},{"id":"T9","span":{"begin":148,"end":158},"obj":"Species"},{"id":"T99","span":{"begin":122,"end":144},"obj":"Gene"}],"relations":[{"id":"R264","pred":"is_a","subj":"T99","obj":"T291"},{"id":"R206","pred":"of_a","subj":"T290","obj":"T108"},{"id":"R210","pred":"of_a","subj":"T9","obj":"T99"},{"id":"R261","pred":"is_a","subj":"T290","obj":"T292"},{"id":"R262","pred":"is_a","subj":"T292","obj":"T291"},{"id":"R263","pred":"to","subj":"T291","obj":"T108"}],"attributes":[{"id":"A307","pred":"tao:has_database_id","subj":"T291","obj":"MESH:D011485"},{"id":"A52","pred":"tao:has_database_id","subj":"T99","obj":"Gene:43740568"},{"id":"A60","pred":"tao:has_database_id","subj":"T108","obj":"Gene:59272"},{"id":"A9","pred":"tao:has_database_id","subj":"T9","obj":"Tax:2697049"},{"id":"A298","pred":"tao:has_database_id","subj":"T290","obj":"MESH:D011994"}],"text":"Recombinant ACE2 (under clinical trials) is also considered as a decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2 [9, 10]."}

{"project":"LitCovid-PubTator-s","denotations":[{"id":"206","span":{"begin":148,"end":158},"obj":"Species"},{"id":"205","span":{"begin":12,"end":16},"obj":"Gene"}],"attributes":[{"id":"A206","pred":"tao:has_database_id","subj":"206","obj":"Tax:2697049"},{"id":"A205","pred":"tao:has_database_id","subj":"205","obj":"Gene:59272"}],"text":"Recombinant ACE2 (under clinical trials) is also considered as a decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2 [9, 10]."}

{"project":"LitCovid-manual","denotations":[{"id":"T99","span":{"begin":122,"end":144},"obj":"Gene"},{"id":"T9","span":{"begin":148,"end":158},"obj":"Species"},{"id":"T292","span":{"begin":95,"end":106},"obj":"NegativeRegulation"},{"id":"T291","span":{"begin":107,"end":114},"obj":"Phenomena"},{"id":"T290","span":{"begin":0,"end":11},"obj":"Type"},{"id":"T108","span":{"begin":12,"end":16},"obj":"Gene"}],"relations":[{"id":"R264","pred":"is_a","subj":"T99","obj":"T291"},{"id":"R263","pred":"to","subj":"T291","obj":"T108"},{"id":"R262","pred":"is_a","subj":"T292","obj":"T291"},{"id":"R261","pred":"is_a","subj":"T290","obj":"T292"},{"id":"R210","pred":"of_a","subj":"T9","obj":"T99"},{"id":"R206","pred":"of_a","subj":"T290","obj":"T108"}],"attributes":[{"id":"A9","pred":"tao:has_database_id","subj":"T9","obj":"Tax:2697049"},{"id":"A307","pred":"tao:has_database_id","subj":"T291","obj":"MESH:D011485"},{"id":"A298","pred":"tao:has_database_id","subj":"T290","obj":"MESH:D011994"},{"id":"A60","pred":"tao:has_database_id","subj":"T108","obj":"Gene:59272"},{"id":"A52","pred":"tao:has_database_id","subj":"T99","obj":"Gene:43740568"}],"text":"Recombinant ACE2 (under clinical trials) is also considered as a decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2 [9, 10]."}

{"project":"Covid19_manual_annotation","denotations":[{"id":"206","span":{"begin":148,"end":158},"obj":"Species"},{"id":"T166","span":{"begin":0,"end":11},"obj":"Recombinant"},{"id":"T287","span":{"begin":12,"end":16},"obj":"Gene"},{"id":"T288","span":{"begin":122,"end":144},"obj":"Biological"},{"id":"T290","span":{"begin":107,"end":114},"obj":"Bind"},{"id":"T291","span":{"begin":65,"end":70},"obj":"Chemical"},{"id":"T292","span":{"begin":95,"end":106},"obj":"Condition"}],"relations":[{"id":"R330","pred":"of_a","subj":"206","obj":"T288"},{"id":"R331","pred":"is_a","subj":"T291","obj":"T287"},{"id":"R332","pred":"has_status","subj":"T290","obj":"T292"},{"id":"R333","pred":"is_a","subj":"T291","obj":"T290"},{"id":"R334","pred":"to","subj":"T290","obj":"T288"},{"id":"R329","pred":"is_a","subj":"T166","obj":"T287"}],"attributes":[{"id":"A206","pred":"tao:has_database_id","subj":"206","obj":"Tax:2697049"},{"id":"A364","pred":"tao:has_database_id","subj":"T287","obj":"Gene:59272"},{"id":"A365","pred":"ForCovid19","subj":"T291","obj":"decoy"}],"text":"Recombinant ACE2 (under clinical trials) is also considered as a decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2 [9, 10]."}